The global wellness market is experiencing unprecedented growth, with consumers increasingly seeking natural, science-backed ingredients for proactive health management. Regulatory bodies are also encouraging transparent, evidence-based claims for functional foods. This patent addresses the critical need for effective, safe, and consumer-acceptable solutions in the rapidly expanding healthy aging segment, particularly for cognitive and motivational support, a market projected to reach over ~$33.5 billion globally (AI est.) by 2030.
Provides significant efficacy: A specific molar ratio of non-gallate catechins to theogallin (0.3 or higher) is expected to improve age-related cognitive dysfunction and low motivation.
Ensures natural safety and high acceptance: Based on tea leaves, a widely consumed natural ingredient, addressing consumer safety concerns and fostering high market acceptance.
Enhances Neurotrophin 3: Demonstrated to boost neurotrophin 3, a neural growth factor in the brain, providing a scientifically substantiated mechanism of action.
This patent protects agents for preventing or improving age-related cognitive dysfunction and low motivation, specifically defining a unique molar ratio (0.3 or higher) of non-gallate catechins to theogallin derived from tea leaves, along with their manufacturing methods. The patent successfully navigated a rejection during examination, demonstrating robust claim strength and clear scope, making it less susceptible to invalidation.
This patent specifically protects a tea leaf extract with a defined catechin-to-theogallin ratio for cognitive and motivational benefits. White space exists for exploring other botanical compounds or synthetic analogs for neurotrophin 3 enhancement, or for developing delivery systems that optimize bioavailability.
The healthy aging market is estimated at ~$2B globally (AI est.), with the cognitive function improvement food market growing at 5% annually. Introducing this technology as a functional food product, with a unit price of ~$33.50 (AI est.) and annual sales of 30,000 units (0.01% market share), could generate approximately ~$1M in new annual revenue (AI est.). This estimate is based on the technology's advantage in a market with limited prior art.
X: Scientific Basis of Action Mechanism
Y: Natural Origin Safety & Acceptance